Sumitomo Mitsui Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Buy
2,300
+300
+15% +$35.1K 0.01% 145
2026
Q1
$241K Buy
+2,000
New +$231K ﹤0.01% 132
2022
Q2
Sell
-210
Closed -$17K 208
2022
Q1
$17K Buy
+210
New +$16.6K ﹤0.01% 190
2020
Q4
Sell
-1,358
Closed -$106K 164
2020
Q3
$106K Buy
+1,358
New +$106K ﹤0.01% 128
2020
Q1
Sell
-4,192
Closed -$366K 145
2019
Q4
$366K Buy
+4,192
New +$344K 0.03% 92
2019
Q2
Sell
-8,384
Closed -$661K 127
2019
Q1
$661K Buy
+8,384
New +$627K 0.06% 69
2017
Q3
Sell
-52
Closed -$3K 119
2017
Q2
$3K Buy
+52
New +$3.17K ﹤0.01% 110

Other funds holding MRK

Sumitomo Mitsui Financial Group's MRK Position: Q2 2026 in Review

Sumitomo Mitsui Financial Group increased its Merck (MRK) stake by 15% in Q2 2026, buying an estimated $35.1K and bringing the position to 2,300 shares worth $296K. The position accounts for 0.01% of the portfolio, ranked #145.

Sumitomo Mitsui Financial Group first reported a position in MRK in Q2 2017 and has held it in 7 quarters since. The position peaked at $661K in Q1 2019. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sumitomo Mitsui Financial Group held 2,300 shares of Merck worth $296K as of Q2 2026.
  • Sumitomo Mitsui Financial Group bought 300 Merck shares in Q2 2026, an estimated $35.1K.
  • Merck made up 0.01% of Sumitomo Mitsui Financial Group's portfolio in Q2 2026, its #145 holding.
  • Sumitomo Mitsui Financial Group first reported a position in Merck in Q2 2017 and has held it in 7 quarters since.
  • Sumitomo Mitsui Financial Group's Merck position peaked at $661K in Q1 2019.
  • 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.